BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23868820)

  • 1. The impact of hyperglycemia on risk of infection and early death during induction therapy for acute lymphoblastic leukemia (ALL).
    Dare JM; Moppett JP; Shield JP; Hunt LP; Stevens MC
    Pediatr Blood Cancer; 2013 Dec; 60(12):E157-9. PubMed ID: 23868820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.
    Afzal S; Ethier MC; Dupuis LL; Tang L; Punnett AS; Richardson SE; Allen U; Abla O; Sung L
    Pediatr Infect Dis J; 2009 Dec; 28(12):1064-8. PubMed ID: 19773675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious profile in children with ALL during chemotherapy: A report of study group for infections.
    Zawitkowska J; Drabko K; Szmydki-Baran A; Zaucha-Prażmo A; Lejman M; Czyżewski K; Zalas-Więcek P; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Kulicka E; Semczuk K; Hutnik Ł; Chełmecka-Wiktorczyk L; Klepacka J; Frączkiewicz J; Salamonowicz M; Tomaszewska R; Zając-Spychała O; Irga-Jaworska N; Bień E; Płonowski M; Bartnik M; Ociepa T; Pierlejewski F; Woszczyk M; Gamrot-Pyka Z; Małas Z; Urbanek-Dądela A; Stolpa W; Musiał J; Styczyński J
    J Infect Chemother; 2019 Oct; 25(10):774-779. PubMed ID: 31101529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma.
    Whittle SB; Williamson KC; Russell HV
    Pediatr Hematol Oncol; 2017 Aug; 34(5):331-342. PubMed ID: 29200325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia.
    Sonabend RY; McKay SV; Okcu MF; Yan J; Haymond MW; Margolin JF
    Pediatr Blood Cancer; 2008 Sep; 51(3):387-92. PubMed ID: 18523991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia.
    Sonabend RY; McKay SV; Okcu MF; Yan J; Haymond MW; Margolin JF
    J Pediatr; 2009 Jul; 155(1):73-8. PubMed ID: 19394046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
    Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
    Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infectious complications of the treatment of acute lymphoblastic leukemia in children].
    Rubie H; Assouline C; Prere MF; Dutour A; Lemozy J; Mouls JL; Gayet-Mengelle C; Robert A
    Pediatrie; 1990; 45(5):333-8. PubMed ID: 2165247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
    Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
    Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
    Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution with doxorubicin for daunorubicin during induction for high risk pediatric acute lymphoblastic leukemia results in increased toxicity.
    Gardner RA; Thomson B; Hawkins DS
    Pediatr Blood Cancer; 2013 Feb; 60(2):338-9. PubMed ID: 23015453
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma.
    Ishihara Y; Kimura S; Akahoshi Y; Harada N; Nakano H; Kameda K; Ugai T; Wada H; Yamasaki R; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Usuki K; Kanda Y
    Hematology; 2016 Jan; 21(1):19-25. PubMed ID: 26352559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
    Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
    J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia.
    Bostrom B; Uppal P; Chu J; Messinger Y; Gandrud L; McEvoy R
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):504-8. PubMed ID: 23823111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Büyükçelik A; Yalçin B; Utkan G; Doruk H
    Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study].
    Zupanić-Krmek D; Nemet D; Mrsić M; Bogdanić V; Labar B; Jandrlić M; Kalenić S
    Acta Med Croatica; 2004; 58(4):275-84. PubMed ID: 15700683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001.
    Christensen MS; Heyman M; Möttönen M; Zeller B; Jonmundsson G; Hasle H;
    Br J Haematol; 2005 Oct; 131(1):50-8. PubMed ID: 16173962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient hyperglycemia during childhood acute lymphocytic leukemia chemotherapy: an old event revisited.
    Spinola-Castro AM; Siviero-Miachon AA; Andreoni S; Tosta-Hernandez PD; Macedo CR; Lee ML
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):465-72. PubMed ID: 19701154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.
    Meir HM; Balawi IA; Meer HM; Nayel H; Al-Mobarak MF
    Saudi Med J; 2001 May; 22(5):423-7. PubMed ID: 11376385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.